With the analysis among 1,747 patents, we discovered top 337 key players by total patent application. Merck Sharp & Dohme Corp., Warner-Lambert Co., Regeneron Pharmaceuticals, Inc. are dominant in this area. They take 14.02% of the total patent filing.
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 102
New Jersey, United States
Patent: 72
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 71
Utrecht, Netherlands
Patent: 53
New York, United States
Patent: 47
New Jersey, United States
Patent: 47
California, United States
Patent: 46
Antwerpen, Belgium
Patent: 40
F. Hoffmann-La Roche Ltd.
New Jersey, United States
Patent: 34
With the analysis among 66 patents, we discovered top 5 start-ups by total patent application. Sapreme Technologies BV, ImmunoMet Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
Utrecht, Netherlands
Patent: 53
ImmunoMet Therapeutics, Inc.
Texas, United States
Patent: 5
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 2
Saskatchewan, Canada
Patent: 2
With the analysis among related 341 patents applied in the last 5 years. We discover 95 most active companies in this area. The fast-growing Sapreme Technologies BV, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Inc. take 29.33% of patent filing during this period.
Utrecht, Netherlands
Patent: 53
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 27
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 20
New Jersey, United States
Patent: 19
Kang Rong Dongfang (Guangdong) Pharmaceutical Co Ltd
Guangdong Sheng, China
Patent: 13
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 12
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 11
Pennsylvania, United States
Patent: 8
Louisiana State University
Louisiana, United States
Patent: 7
Pennsylvania, United States
Patent: 7
With the analysis among related 341 patents in last 5 years, we discover 61 new entrants. Sapreme Technologies BV, Kang Rong Dongfang (Guangdong) Pharmaceutical Co Ltd, Charité - Universitätsmedizin Berlin are the most active new entrants in this area.
Utrecht, Netherlands
Patent: 53
Kang Rong Dongfang (Guangdong) Pharmaceutical Co Ltd
Guangdong Sheng, China
Patent: 13
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 12
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 11
Pennsylvania, United States
Patent: 8
Louisiana State University
Louisiana, United States
Patent: 7
BRISTOL, United Kingdom
Patent: 7
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 6
Hongying Biotechnology Co., Ltd
undefined undefined
Patent: 4
With the analysis among 170 patents, we discovered top 50 universities and scientific research institutions by total patent application. Charité - Universitätsmedizin Berlin, Louisiana State University, Wake Forest University are dominant in this area. They take 24.71% of the total patent filing.
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 12
Louisiana State University
Louisiana, United States
Patent: 7
North Carolina, United States
Patent: 6
Korea Institute of Science & Technology
Virginia Commonwealth University
Virginia, United States
Patent: 3
Hubei Sheng, China
Patent: 3
East China Normal University
Shanghai Shi, China
Patent: 3
University of San Agustin
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 3